Spyre Therapeutics
SYRE
#4522
Rank
S$2.34 B
Marketcap
$45.98
Share price
3.29%
Change (1 day)
197.30%
Change (1 year)

Spyre Therapeutics (SYRE) - Total debt

Total debt on the balance sheet as of December 2023 : N/A

According to Spyre Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Spyre Therapeutics - Total debt on balance sheet (from 2018 to 2023)

Total debt by year

Year Total debt Change
2023-12-31N/A-100%
2022-12-31S$6.2 M-9.28%
2021-12-31S$6.84 M-5.09%
2020-12-31S$7.2 M5.59%
2019-12-31S$6.82 M
2018-12-31N/A